These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33811512)

  • 21. Diode Laser Vaporization for Benign Prostate Hyperplasia: Outcome After 126 Procedures.
    Tanaka EY; Barbosa FT; Murta CB; Claro JF; Manzano JP
    J Endourol; 2019 Dec; 33(12):1025-1031. PubMed ID: 31829910
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety and Feasibility of Soractelite Transperineal Focal Laser Ablation for Prostate Cancer and Short-term Quality of Life Analysis from a Multicenter Pilot Study.
    van Riel LAMJG; van Kollenburg RAA; Vis AN; van Leeuwen PJ; de Reijke TM; de Bruin DM; Oddens JR
    Eur Urol Open Sci; 2022 May; 39():48-54. PubMed ID: 35528781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relief of Lower Urinary Tract Symptoms After MRI-Guided Transurethral Ultrasound Ablation for Localized Prostate Cancer: Subgroup Analyses in Patients with Concurrent Cancer and Benign Prostatic Hyperplasia.
    Elterman D; Li W; Hatiboglu G; Relle J; Zorn KC; Bhojani N; Chin J
    J Endourol; 2021 Apr; 35(4):497-505. PubMed ID: 32935575
    [No Abstract]   [Full Text] [Related]  

  • 24. Operative profile, safety and functional outcomes after GreenLight laser prostate surgery: results from a 12 months follow-up multicenter Italian cohort analyses.
    Reale G; Marchioni M; Altieri V; Greco F; De Nunzio C; Destefanis P; Ricciardulli S; Bergamaschi F; Fasolis G; Varvello F; Voce S; Palmieri F; Divan C; Malossini G; Oriti R; Tuccio A; Ruggera L; Tubaro A; Delicato G; Laganà A; Dadone C; De Rienzo G; Ditonno A; Frattini A; Pucci L; Carrino M; Montefiore F; Germani S; Miano R; Schips L; Rabito S; Ferrari G; Cindolo L
    Minerva Urol Nefrol; 2020 Oct; 72(5):622-628. PubMed ID: 32284526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transurethral bipolar plasmakinetic resection combined with 2 μm continuous wave laser vaporization: a new method for the treatment of large volume benign prostatic hyperplasia.
    Liao N; Yu J
    Photomed Laser Surg; 2012 Jun; 30(6):320-4. PubMed ID: 22472069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
    Peng B; Wang GC; Zheng JH; Xia SQ; Geng J; Che JP; Yan Y; Huang JH; Xu YF; Yang B
    BJU Int; 2013 Apr; 111(4):633-7. PubMed ID: 23107074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transperineal Laser Ablation of the Prostate (TPLA) for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction.
    Sessa F; Polverino P; Siena G; Bisegna C; Lo Re M; Spatafora P; Pecoraro A; Rivetti A; Moscardi L; Saladino M; Cocci A; Gacci M; Li Marzi V; Carini M; Minervini A; Campi R; Serni S
    J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Could transperineal interstitial laser ablation of the prostate be the right option for highly-comorbid patients with lower urinary tract symptoms due to benign prostatic obstruction? A preliminary single-center experience focusing on functional and safety outcomes.
    Polverino P; Lo Re M; Saladino M; Pecoraro A; Moscardi L; Rivetti A; Resta GR; Pezzoli M; Romano A; Somani BK; Siena G; Cocci A; Gacci M; Minervini A; Serni S; Campi R; Sessa F
    Minerva Urol Nephrol; 2023 Dec; ():. PubMed ID: 38093618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GreenLight laser photoselective vaporization of the prostate for treatment of benign prostate hyperplasia/lower urinary tract symptoms in patients with different post-void residual urine.
    Luo F; Sun HH; Su YH; Zhang ZH; Wang YS; Zhao Z; Li J
    Lasers Med Sci; 2017 May; 32(4):895-901. PubMed ID: 28293871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaporize, anatomically vaporize or enucleate the prostate? The flexible use of the GreenLight laser.
    Cindolo L; Ruggera L; Destefanis P; Dadone C; Ferrari G
    Int Urol Nephrol; 2017 Mar; 49(3):405-411. PubMed ID: 28044238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of vaporization using 120-W GreenLight laser versus 2-micrometer continuous laser for treating benign prostatic hyperplasia: A 24-month follow-up study of a single center.
    Tao W; Xue B; Sun C; Yang D; Zhang Y; Shan Y
    J Xray Sci Technol; 2019; 27(4):755-764. PubMed ID: 31256112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-in-man Safety and Efficacy of the ClearRing Implant for the Treatment of Benign Prostatic Hyperplasia.
    Vjaters E; Nitsan D; Mullerad M; Engelstein D; Leibovitch I; Feld Y
    Eur Urol Focus; 2020 Jan; 6(1):131-136. PubMed ID: 30293945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of preoperative detrusor underactivity on long-term surgical outcomes of photovaporization and holmium laser enucleation in men with benign prostatic hyperplasia: a lesson from 5-year serial follow-up data.
    Cho MC; Yoo S; Park J; Cho SY; Son H; Oh SJ; Paick JS
    BJU Int; 2019 May; 123(5A):E34-E42. PubMed ID: 30582661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of 180W XPS GreenLight laser vaporization of the prostate for treatment of benign prostatic hyperplasia.
    Tao W; Sun C; Yang D; Zang Y; Zhu J; Zhang Y; Wang G; Xue B
    J Xray Sci Technol; 2019; 27(6):1121-1129. PubMed ID: 31498146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transperineal laser ablation as a new minimally invasive surgical therapy for benign prostatic hyperplasia: a systematic review of existing literature.
    Tzelves L; Nagasubramanian S; Pinitas A; Juliebø-Jones P; Madaan S; Sienna G; Somani B
    Ther Adv Urol; 2023; 15():17562872231198634. PubMed ID: 37745187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study.
    De Nunzio C; Cantiello F; Fiori C; Crocerossa F; Tognoni P; Amparore D; Baldassarri V; Elbers JR; Sancha FG; Porpiglia F
    World J Urol; 2021 Jun; 39(6):2037-2042. PubMed ID: 32851439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Dixon C; Cedano ER; Pacik D; Vit V; Varga G; Wagrell L; Tornblom M; Mynderse L; Larson T
    Urology; 2015 Nov; 86(5):1042-7. PubMed ID: 26216644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Diode Laser (980 nm) Enucleation
    He G; Shu Y; Wang B; Du C; Chen J; Wen J
    J Endourol; 2019 Oct; 33(10):843-849. PubMed ID: 31298571
    [No Abstract]   [Full Text] [Related]  

  • 40. Holmium:YAG laser resection of the prostate versus visual laser ablation of the prostate and transurethral ultrasound-guided laser induced prostatectomy: a retrospective comparative study.
    Kitagawa M; Furuse H; Fukuta K; Aso Y
    Int J Urol; 1998 Mar; 5(2):152-6. PubMed ID: 9559841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.